On Demand 2018 Monday General Sessions

This collection covers general sessions from Monday's program. The sessions listed below are included in this package:

  • Collaborations and Challenges in Clinical Practice
  • How Allergists Can Help Prevent Food Allergy Development: Translating Evidence into Practice 
  • Evaluation of a Patient with Secondary Immune Deficiency

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Describe the signs and symptoms of anaphylaxis
  • Recognize the various lay organizations and their missions, and develop an interest in helping them at a local level
  • Discuss data from publicly available databases to illustrate the benefits of using large data sets to advance understanding of prevalence and change guidelines regarding food allergy prevention.
  • Review evidence supporting interventions during pregnancy, breast feeding and infancy that may impact food allergy development.
  • Apply practical approaches to help facilitate discussion with caregivers and supply resources.
  • Recognize and evaluate patients for common immune defects associated with underlying conditions and therapy for malignancies and autoimmune disorders.
  • Describe the risk factors for developing immune system dysfunction associated with the use of systemic steroids or immunomodulators.
  • Discuss therapeutic options to treat secondary immune deficiencies.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (College) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, or evaluation of content for a CME activity. Financial disclosures are reviewed in advance, to ensure any potential conflicts of interest are resolved. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Specific disclosure information for the 2018 Annual Meeting is now available online.

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
  • 3.00 MOC
Course opens: 
12/01/2018
Course expires: 
11/30/2021
Part of: 
On Demand 2018 ACAAI Annual Meeting: General Sessions
Rating: 
0

Julie Block

Anne K. Ellis, MD, MSc, FACAAI

Eleanor Garrow

Kathleen E. Gundling, MD

Ruchi Gupta, MD, MPH

Monica G. Lawrence, MD

Todd A. Mahr, MD, FACAAI

Kenneth Mendez, MBA

Anthony Montanaro, MD, FACAAI

Syed Shahzad Mustafa, MD, FACAAI

Michael Pistiner, MD, MMSc, FACAAI

John Routes, MD

Carina Venter, PhD, RD

Harold P. Wimmer 

Tonya Winders, MBA

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
  • 3.00 MOC
Please login or create an account to take this course.